Lamda Gen Corporation
Biotechnology, 1455 Adams Dr, Menlo Park, California, 94025, United States, 1-10 Employees
Phone Number: 65********
Who is LAMDAGEN CORPORATION
LamdaGen Corporation is an innovative technology company at the forefront of developing and integrating powerful plasmonic biosensors for a wide range of applications. Our primary focus i...
Read More
-
Headquarters: 1455 Adams Dr, Menlo Park, California, 94025, United States
-
Employees: 1-10
-
Revenue: Under $1 Million
-
CEO:
Randy Storer
Email
Phone
Industry: Biotechnology
SIC Code: 3821
|
NAICS Code: 531110 |
Show More
Does something look wrong? Fix it. | View contact records from LAMDAGEN CORPORATION
LamdaGen Corporation Org Chart and Mapping
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding LamdaGen Corporation
Answer: LamdaGen Corporation's headquarters are located at 1455 Adams Dr, Menlo Park, California, 94025, United States
Answer: LamdaGen Corporation's phone number is 65********
Answer: LamdaGen Corporation's official website is https://lamdagen.com
Answer: LamdaGen Corporation's revenue is Under $1 Million
Answer: LamdaGen Corporation's SIC: 3821
Answer: LamdaGen Corporation's NAICS: 531110
Answer: LamdaGen Corporation has 1-10 employees
Answer: LamdaGen Corporation is in Biotechnology
Answer: LamdaGen Corporation contact info: Phone number: 65******** Website: https://lamdagen.com
Answer: LamdaGen Corporation is an innovative technology company at the forefront of developing and integrating powerful plasmonic biosensors for a wide range of applications. Our primary focus is on enabling rapid point-of-use diagnostic and detection systems that require exceptional sensitivity and precise quantitation. To achieve this, we have developed the LAuRA Digital Diagnostic System, which utilizes our proprietary plasmonic biosensors as the core technology, supported by our patented Plasmonic Amplification TechnologyTM (PATTM). PAT represents a significant breakthrough in the realm of rapid, high-sensitivity detection, featuring a unique double amplification system. This technology allows our products to combine the speed and convenience of lateral flow assay (LFA) technologies with the exceptional sensitivity and quantitation capabilities of microtiter plate enzyme-linked immunosorbent assays (ELISA). As a technology holding company, LamdaGen follows a serial spin-off licensing model to optimize the value of our biosensor-based technologies. We leverage our expertise and intellectual property to expand into various sectors, including Food and Water Safety, Human Health, Animal Health, and Environmental Health. Through strategic partnerships with industry leaders in these sectors, we are applying our powerful biosensor technology to a broad range of applications, facilitating significant advancements in diagnostic capabilities and enhancing overall safety and well-being. At LamdaGen, our vision is to revolutionize the field of biosensing by consistently pushing the boundaries of sensitivity, speed, and precision for commercial use. We remain committed to delivering cutting-edge solutions that address critical needs across diverse industries, ultimately improving health outcomes and enabling more effective decision-making processes. We invite you to explore partnering opportunities with us.
Answer:
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month